Biomarker analyses of second-line ramucirumab in patients...

European Journal of Cancer 2020 / 03 Vol. 127

Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study

Van Cutsem, E., Muro, K., Cunningham, D., Bodoky, G., Sobrero, A., Cascinu, S., Ajani, J., Oh, S.C., Al-Batran, S.E., Wainberg, Z.A., Wijayawardana, S.R., Melemed, S., Ferry, D., Hozak, R.R., Ohtsu, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
127
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2019.10.026
Date:
March, 2020
File:
PDF, 749 KB
2020
Conversion to is in progress
Conversion to is failed